KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Long-Term Deferred Tax: 2016-2023

Historic Long-Term Deferred Tax for BeOne Medicines (ONC) over the last 7 years, with Dec 2023 value amounting to $2.0 billion.

  • BeOne Medicines' Long-Term Deferred Tax fell 2.38% to $2.0 billion in Q4 2023 from the same period last year, while for Dec 2023 it was $2.0 billion, marking a year-over-year decrease of 2.38%. This contributed to the annual value of $2.0 billion for FY2023, which is 2.38% down from last year.
  • Latest data reveals that BeOne Medicines reported Long-Term Deferred Tax of $2.0 billion as of FY2023, which was down 2.38% from $2.1 billion recorded in FY2022.
  • In the past 5 years, BeOne Medicines' Long-Term Deferred Tax ranged from a high of $2.1 billion in FY2022 and a low of $37.9 million during FY2019.
  • Over the past 2 years, BeOne Medicines' median Long-Term Deferred Tax value was $2.1 billion (recorded in 2022), while the average stood at $2.1 billion.
  • Per our database at Business Quant, BeOne Medicines' Long-Term Deferred Tax spiked by 74.07% in 2020 and then declined by 2.38% in 2023.
  • Over the past 4 years, BeOne Medicines' Long-Term Deferred Tax (Yearly) stood at $37.9 million in 2019, then surged by 74.07% to $66.0 million in 2020, then reached $2.1 billion in 2022, then declined by 2.38% to $2.0 billion in 2023.